The overall uptake of RSV vaccine is low during its first season in those aged 60 years or older in the United States. The knowledge of the vaccine and its eligibility is limited.

I am recommending a COVID booster this spring for my highest-risk patients — those with immune system diseases and older ...

After the monoclonal antibody nirsevimab (Beyfortus) became available to prevent respiratory syncytial virus (RSV) in infants ...

In a recent study of a population of infants, published online May 6 in Pediatrics, 72% of infants were found to be immunized ...

People who are given a vaccine for shingles have a 23% lower risk of cardiovascular events, including stroke, heart failure, and coronary heart disease, according to a recent study of more than a ...

Overall, 72% of 36,949 infants were immunized in the 2023-2024 RSV season with either the bivalent RSV prefusion F protein ...

CDC's RSV vaccine recommendations from Pfizer and GSK face review by HHS advisor William "Reyn" Archer III. Read more here.

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

By Dennis Thompson HealthDay ReporterTUESDAY, May 6, 2025 (HealthDay News) -- Newborns can be effectively protected against ...

I am a 74-year-old man with no major health issues. Over the past several years, I have been getting a COVID booster in the spring with a ...

New Zealand has the world's highest rates of serious illness caused by RSV, with 2000 children under five admitted to hospital each year.

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...